Alina Franzen
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Assessment of Flexible Single-Use Rhinolaryngoscopes with Working Channel in the Upper Airways
Journal: Laryngo- rhino- otologie
Published: May 09, 2025
Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma.
Journal: Clinical chemistry
Published: July 26, 2023
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.
Journal: Clinical epigenetics
Published: December 20, 2022
Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
Journal: Clinical chemistry
Published: November 23, 2022
CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With BAP1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: January 04, 2022
DNA Methylation and mRNA Expression of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) in Head and Neck Squamous Cell Carcinoma Correlates With HPV Status, Mutational Load, an Interferon-γ Signature, Signatures of Immune Infiltrates, and Survival.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: August 11, 2021
PD-1, CTLA4, PD-L1 and PD-L2 DNA methylation in papillary thyroid carcinoma.
Journal: Immunotherapy
Published: July 21, 2020
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Journal: PloS one
Published: September 08, 2017
PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas.
Journal: Oncotarget
Published: May 31, 2017
Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
Journal: Clinical epigenetics
Published: April 29, 2017
Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
Journal: Clinical chemistry
Published: December 14, 2016
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.
Journal: Clinical epigenetics
Published: November 27, 2016
Last Updated: 09/26/2026